Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obesity Surgery. 2018;28(12):3783–3794. doi: 10.1007/s11695-018-3450-2.
Caruso A, Gelsomino L, Panza S, et al. Leptin: A heavyweight player in obesity-related cancers. Biomolecules. 2023;13(7):1084.
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356.
Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity management in adults: A review. JAMA. 2023 Nov 28;330(20):2000-15. doi:10.1001/jama.2023.1989.
Ganipisetti VM, Bollimunta P. Obesity and set-point theory. [Updated 2023 Apr 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Accessed at https://www.ncbi.nlm.nih.gov/books/NBK592402/ on July 30, 2025.
Lim RB. Bariatric procedures for the management of severe obesity: Descriptions. UpToDate. 2023. Accessed at https://www.uptodate.com/contents/bariatric-procedures-for-the-management-of-severe-obesity-descriptions on July 30, 2025.
Lin C, et al. Comparative risk of obesity-related cancer with glucagon-like protein-1 receptor agonists vs. bariatric surgery in patients with BMI >35. Journal of Clinical Oncology. 2024; 42(16):suppl. doi.org/10.1200/JCO.2024.42.16_suppl.10508.
López M, Nogueiras R. Ghrelin. Current Biology. 2023;33(21):R1133-1135. DOI: 10.1016/j.cub.2023.09.009
Wilson RB, Lathigara D, Kaushal D. Systematic review and meta-analysis of the impact of bariatric surgery on future cancer risk. Int J Mol Sci. 2023; 24(7):6192. https://doi.org/10.3390/ijms24076192